atazanavir sulfate has been researched along with Leishmaniasis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvarenga, DLR; Alves, ÉAR; Calzavara-Silva, CE; de Oliveira, JG; Fiuza, JA; Gaze, ST; Oliveira, RC; Pascoal-Xavier, MA; Silva, AHDS | 1 |
Alves, ÉAR; Borges, TK; de Miranda, MG; Magalhães, KG; Muniz-Junqueira, MI | 1 |
2 other study(ies) available for atazanavir sulfate and Leishmaniasis
Article | Year |
---|---|
HIV aspartyl protease inhibitors modify the percentage of activated leukocytes, as well as serum levels of IL-17A and NO during experimental leishmaniasis.
Topics: Animals; Atazanavir Sulfate; Cytokines; Female; HIV Protease Inhibitors; Leishmaniasis; Leukocyte Count; Leukocytes; Lopinavir; Mice, Inbred BALB C; Nitric Oxide; Ritonavir; Skin; Spleen | 2018 |
Anti-HIV drugs, lopinavir/ritonavir and atazanavir, modulate innate immune response triggered by Leishmania in macrophages: the role of NF-κB and PPAR-γ.
Topics: Animals; Anti-HIV Agents; Atazanavir Sulfate; Cells, Cultured; Cytokines; Female; Hydrogen Peroxide; Immunity, Innate; Leishmania; Leishmaniasis; Lopinavir; Macrophages, Peritoneal; Mice, Inbred BALB C; NF-kappa B; Nitrites; PPAR gamma; Ritonavir | 2015 |